Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Arthritis care & research

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.23119PMID 27723283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

  2016cited by this paper
• Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

  2016cited by this paper
• Stratification of ALS patients’ survival: a population-based study

  2016cited by this paper
• Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis

  2016cited by this paper
• Incidence of Cataract Surgery in Patients After Percutaneous Cardiac Intervention in Taiwan.

  2016cited by this paper
• Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Pattern of Respiratory Deterioration in Sporadic Amyotrophic Lateral Sclerosis According to Onset Lesion by Using Respiratory Function Tests

  2015cited by this paper
• Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients

  2015cited by this paper
• Hypothermia Reduces but Hyperthermia Augments T Cell-Derived Release of Interleukin-17 and Granzyme B that Mediate Neuronal Cell Death

  2015cited by this paper
• Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families.

  2015cited by this paper
• Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study.

  2015cited by this paper
• Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort

  2014cited by this paper
• Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case-control study in Taiwan.

  2014cited by this paper
• Current pathways for epidemiological research in amyotrophic lateral sclerosis

  2013cited by this paper
• Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997–2011

  2013cited by this paper
• CNS-Targeted Production of IL-17A Induces Glial Activation, Microvascular Pathology and Enhances the Neuroinflammatory Response to Systemic Endotoxemia

  2013cited by this paper
• Lifetime physical activity and the risk of amyotrophic lateral sclerosis

  2013cited by this paper
• Autoimmune disease preceding amyotrophic lateral sclerosis

  2013influential reference
• Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

  2013cited by this paper
• Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1.

  2012cited by this paper
• Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.

  2012cited by this paper
• Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

  2011cited by this paper
• Epidemiological survey of orthopedic joint dislocations based on nationwide insurance data in Taiwan, 2000-2005

  2011influential reference
• Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.

  2011cited by this paper
• Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.

  2010cited by this paper
• The sex ratio in amyotrophic lateral sclerosis: A population based study

  2010cited by this paper
• Interleukin‐17 and interleukin‐23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?

  2010cited by this paper
• Nationwide Population-Based Epidemiological Study of Myasthenia Gravis in Taiwan

  2010cited by this paper
• Familial risks for amyotrophic lateral sclerosis and autoimmune diseases

  2009cited by this paper
• Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.

  2009cited by this paper
• Incidence of amyotrophic lateral sclerosis in Europe

  2009cited by this paper
• Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

  2005cited by this paper
• Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.

  2004cited by this paper
• Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

  2004cited by this paper
• Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000

  2003cited by this paper
• Reduced Hippocampal Neurogenesis in Adult Transgenic Mice with Chronic Astrocytic Production of Interleukin-6

  2002cited by this paper
• Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis.

  2001influential reference
• Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis.

  2000cited by this paper
• Tumor necrosis factor-α expression in muscles of polymyositis and dermatomyositis

  2000cited by this paper
• Neurotoxic Effects of lnterleukin-6 and Sodium Nitroprusside on Cultured Rat Hippocampal Neurons

  2000cited by this paper
• A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis.

  1996cited by this paper
• The quality of care and symptom control--the effects on the terminal phase of ALS/MND.

  1996cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].

  1993cited by this paper
• Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.

  1992cited by this paper
• Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

  1984cited by this paper
• Histocompatibility typing in amyotrophic lateral sclerosis.

  1976cited by this paper
• Factors affecting survivorship in polymyositis. A life-table study of 124 patients.

  1971cited by this paper
• UMOR NECROSIS FACTOR ALPHA AND INTERFERON GAMMA OOPERATIVELY INDUCE OXIDATIVE STRESS AND MOTONEURON EATH IN RAT SPINAL CORD EMBRYONIC EXPLANTS

  year unknowncited by this paper

• Anti-PL12 Anti-Synthetase Syndrome and Amyotrophic Lateral Sclerosis: A Case Report of a Rare Comorbidity

  2023cites this paper
• ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study

  2021cites this paper
• Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study

  2020cites this paper
• Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation : nationwide epidemiological studies on etiology, comorbidities, and treatment

  2019cites this paper
• SLA et myopathie inflammatoire un choix difficile !

  2018cites this paper